NCT06368947 Therapeutic Play on Pain Tolerance and Emotion Regulation in Children
| NCT ID | NCT06368947 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ataturk University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2024-04-29 |
| Primary Completion | 2024-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2024-04-29 with a primary completion date of 2024-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research is a randomized controlled experimental study. The population of the research will consist of 10-18 year old children who were diagnosed with acute lymphoblastic leukemia and received chemotherapy, who were admitted to the Children's Hematology Clinic of Adana City Training and Research Hospital between 19.05.2024 and 19.05.2025. Therapeutic play sessions will occur over a 4-week period during chemotherapy treatment.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 10-18 * Diagnosed with acute lymphoblastic leukemia * Those receiving chemotherapy treatment * Children who do not have a chronic disease other than the diagnosis of the disease in question Exclusion Criteria: * Under 10 years of age or over 18 years of age * Diagnosed other than acute lymphoblastic leukemia * Not receiving chemotherapy treatment * Children with chronic diseases other than the diagnosis of the disease in question
Frequently Asked Questions
Who can join the NCT06368947 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06368947 currently recruiting?
Yes, NCT06368947 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ataturk University to inquire about joining.
Where is the NCT06368947 trial being conducted?
This trial is being conducted at Erzurum, Turkey (Türkiye).
Who is sponsoring the NCT06368947 clinical trial?
NCT06368947 is sponsored by Ataturk University. The trial plans to enroll 66 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.